PNGAF (The Precision Peptide Co) Total Liabilities: $0.28 Mil (As of Jan. 2026)


PNGAF The Precision Peptide Co Inc PNGAF
21 GF Score
Price $0.34
! 4 Warning Signs
View Full Analysis

What is The Precision Peptide Co Total Liabilities?

The Precision Peptide Co PNGAF -1.93% 21 Total Liabilities is $0.28 Mil as of Jan. 2026. GuruFocus rates PNGAF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review.

The Precision Peptide Co's Total Liabilities for the quarter that ended in Jan. 2026 was $0.28 Mil.

The Precision Peptide Co's quarterly Total Liabilities increased from Jul. 2025 ($0.22 Mil) to Oct. 2025 ($0.29 Mil) but then declined from Oct. 2025 ($0.29 Mil) to Jan. 2026 ($0.28 Mil).

The Precision Peptide Co's annual Total Liabilities increased from Oct. 2023 ($0.24 Mil) to Oct. 2024 ($0.53 Mil) but then declined from Oct. 2024 ($0.53 Mil) to Oct. 2025 ($0.29 Mil).


The Precision Peptide Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for The Precision Peptide Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Precision Peptide Co Total Liabilities Chart

The Precision Peptide Co Annual Data
Trend Oct21 Oct22 Oct23 Oct24 Oct25
Total Liabilities
0.09 0.21 0.24 0.53 0.29

The Precision Peptide Co Quarterly Data
Jul21 Oct21 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.37 0.22 0.29 0.28
PNGAF
21GF Score
The Precision Peptide Co Inc PNGAF
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Precision Peptide Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

The Precision Peptide Co's Total Liabilities for the fiscal year that ended in Oct. 2025 is calculated as

Total Liabilities=Total Assets (A: Oct. 2025 )-Total Equity (A: Oct. 2025 )
=0.952-0.665
=0.29

The Precision Peptide Co's Total Liabilities for the quarter that ended in Jan. 2026 is calculated as

Total Liabilities=Total Assets (Q: Jan. 2026 )-Total Equity (Q: Jan. 2026 )
=0.473-0.195
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $0.28 Mil mean?
The Precision Peptide Co (PNGAF) has a Total Liabilities of $0.28 Mil as of Jan. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for The Precision Peptide Co and its competitors.
Is The Precision Peptide Co's Total Liabilities too high?
The Precision Peptide Co's current Total Liabilities is $0.28 Mil. Overall, The Precision Peptide Co has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The Precision Peptide Co's Total Liabilities compare to KHC and GIS?
The Precision Peptide Co's Total Liabilities of $0.28 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for The Precision Peptide Co and its competitors. The Precision Peptide Co's current Total Liabilities is $0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Precision Peptide Co stock overvalued right now?
The Precision Peptide Co (PNGAF) has a current Total Liabilities of $0.28 Mil. The current Total Liabilities is $0.28 Mil. The Precision Peptide Co's overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For The Precision Peptide Co (PNGAF), the current Total Liabilities is $0.28 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Precision Peptide Co Business Description

Other Exchanges XU0:GermanyBPC:Canada
Address 130th Street, Suite 8035, Surrey, BC, CAN, V3W 0H7
The Precision Peptide Co Inc is a food manufacturer and distributor of nutritional supplements, functional snacks, natural foods, peptides, and natural personal care products. The company offers end-to-end services from formulation and ingredient sourcing to final packaging and fulfillment. The Company has two reportable operating segments: the manufacturing and distribution of food products in Canada and the sale and delivery of its peptide products in the United States.
21GF Score

Get the complete analysis for PNGAF

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.34
Price